Insider · CIK 0001967379
Reazur Rasul
officer
Files at BAX (BAXTER INTERNATIONAL INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | BAX BAXTER INTERNATIONAL INC | FTax withholding Common Stock, $1 par value | -12,674 | $17.69 | $224k | 125,557 | Mar 10, 2026 |
| Mar 2, 2026 | BAX BAXTER INTERNATIONAL INC | FTax withholding Common Stock, $1 par value | -1,614 | $19.69 | $32k | 138,231 | Mar 3, 2026 |
| Feb 9, 2026 | BAX BAXTER INTERNATIONAL INC | AGrant or award Common Stock, $1 par value | +18,951 | $0.00 | $0 | 145,616 | Feb 11, 2026 |
| Feb 9, 2026 | BAX BAXTER INTERNATIONAL INC | FTax withholding Common Stock, $1 par value | -5,770 | $21.73 | $125k | 139,846 | Feb 11, 2026 |
| Mar 6, 2025 | BAX BAXTER INTERNATIONAL INC | FTax withholding Common Stock, $1 par value | -9,341 | $35.44 | $331k | 98,394 | Mar 10, 2025 |
| Mar 6, 2025 | BAX BAXTER INTERNATIONAL INC | AGrant or award Common Stock, $1 par value | +26,220 | $0.00 | $0 | 124,614 | Mar 10, 2025 |
| Mar 6, 2025 | BAX BAXTER INTERNATIONAL INC | AGrant or award Stock Option (Right to Buy)derivative | +87,417 | $0.00 | $0 | 87,417 | Mar 10, 2025 |
| Mar 3, 2025 | BAX BAXTER INTERNATIONAL INC | FTax withholding Common Stock, $1 par value | -1,987 | $34.86 | $69k | 107,735 | Mar 5, 2025 |
| Dec 2, 2024 | BAX BAXTER INTERNATIONAL INC | FTax withholding Common Stock, $1 par value | -2,032 | $33.55 | $68k | 109,116 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.